Kayler Liise K, Kiss Lawrence, Sharma Vivek, Mohanka Ravi, Zeevi Adriana, Girnita Alin, Shapiro Ron, Randhawa Parmjeet S
Department of Surgery, University of Florida Medical Center, Gainesville, FL 32610-0286, USA.
Transplantation. 2008 Mar 27;85(6):813-20. doi: 10.1097/TP.0b013e3181669194.
Focal PTC C4d staining in acute renal allograft rejection has not been studied extensively.
Renal allograft biopsies performed after October 2003, representing the first episode of acute rejection (AR) in recipients with > or = 12 months follow-up postbiopsy, were assessed for extent of C4d and correlated with morphology, ELISA screen, donor-specific antibodies (DSA), response to treatment, and outcome.
In 106 biopsies (16 C4d-diffuse; 24 C4d-focal; 66 C4d-negative), there were no differences among the three groups in terms of timing or grade of AR, creatinine level, tacrolimus level, and grade of interstitial fibrosis/tubular atrophy or graft loss. The C4d-diffuse group was significantly associated with less tubulitis (P=0.0021), and more chronic allograft arteriopathy (P=0.0527). Incomplete response to steroid therapy was more frequent in C4d-diffuse/focal compared with negative cases (P=0.0492). DSA frequency within 1 year of AR was highest in the C4d-diffuse (94%), followed by C4d-focal (38%), and C4d-negative (17%) groups (P<0.0001).
Focal PTC C4d was associated with circulating antibodies, with a 2-fold greater diagnostic sensitivity than negative C4d staining. The finding of diffuse C4d on follow-up biopsy was significantly associated with graft loss at 1 year, regardless of index biopsy C4d results.
急性肾移植排斥反应中局灶性PTC C4d染色尚未得到广泛研究。
对2003年10月以后进行的肾移植活检组织进行评估,这些活检组织代表活检后随访≥12个月的受者首次急性排斥反应(AR),评估C4d的程度,并与形态学、ELISA筛查、供者特异性抗体(DSA)、治疗反应和结局进行相关性分析。
在106例活检组织中(16例C4d弥漫性;24例C4d局灶性;66例C4d阴性),三组在AR的发生时间或分级、肌酐水平、他克莫司水平、间质纤维化/肾小管萎缩分级或移植肾丢失方面无差异。C4d弥漫性组与较少的肾小管炎显著相关(P = 0.0021),且慢性移植肾动脉病较多(P = 0.0527)。与阴性病例相比,C4d弥漫性/局灶性组对类固醇治疗的不完全反应更常见(P = 0.0492)。AR发生1年内DSA的频率在C4d弥漫性组最高(94%),其次是C4d局灶性组(38%)和C4d阴性组(17%)(P<0.0001)。
局灶性PTC C4d与循环抗体相关,诊断敏感性比C4d阴性染色高2倍。随访活检发现弥漫性C4d与1年时移植肾丢失显著相关,无论初次活检C4d结果如何。